Efficacy of Tacrolimus plus Narrow Band Ultraviolet B Phototherapy versus Narrow Band Ultraviolet B Phototherapy alone in the Treatment of Vitiligo

Authors

  • Somaiya Rehman
  • Farooq Azam Khan
  • Hina Zahoor
  • Nafila Taqweem
  • Sahibzada Mahmood Noor
  • Nuzhat Naheed

DOI:

https://doi.org/10.63682/jns.v14i32S.9866

Keywords:

Efficacy, Tacrolimus, Narrow Band, vitiligo.

Abstract

Introduction: Vitiligo Is Considered As One Of The Most Prevalent Depigmentary Condition Affecting 3-4 % Of Indian Population. In Pakistan The Reported Prevalence Is 4.4- 7.5 %. Vitiligo Is Divided Into Generalized Or Non-Segmental Vitiligo Characterized By White Patches, Therapies Include Topical Corticosteroids, Topical Immunomodulators, Calcium Modulators, Phototherapy, Surgery, Laser, Combination Therapies, Depigmentation Of Normally Pigmented Skin And Adjunctive Therapies Like Sunscreen And Camouflage Are Used.

Objective: To Compare The Efficacy Of Tacrolimus Plus Narrow Band Ultraviolet B Phototherapy Versus Narrow Band Ultraviolet B Phototherapy Alone In The Treatment Of Vitiligo.

Methodology: The Current Randomized Controlled Trial Was Carried Out At The Department Of Dermatology, Lady Reading Hospital, Peshawar For A Period Of Six Months From January 2023 To June 2023. Total Sample Size Was 94 Patients I.E 47 In Each Group. All Patients Were Randomly Allocated Into Two Groups By Lottery Method. Patients In Group A Were Subjected To Combined Treatment I.E; Narrow-Band Ultraviolet B Three Times A Week Plus Topical Tacrolimus 0.1% Once Daily Application While Patients In Group B Were Subjected To Narrow-Band Ultraviolet B Three Times A Week Alone For Three Months. Assessments At Baseline And Repigmentation Of Vitiligo Areas On Follow Up After 12 Weeks Was Recorded. Data Were Analyzed In Spss Version 24

Result: A Total Of 94 Patients Were Observed, Which Were Divided In Two Equal Groups. Male To Female Ratio Was 0.59:1. Average Age Was 28.59 Years+ 8.86sd With Range 15-51 Years. Efficacy Wise Distribution Was Significant With P-Value = 0.022. Group Group A Showed 41(87.2%) Efficacy While Non-Effective In 6(12.8%) Patients. Similarly Group B Showed 32(68.1%) Efficacy While Non Effective In 15(31.9%) Patients. The Combination Therapy Have Greater Efficacy Than Monotherapy.


Conclusion: Combination Therapy Is More Effective Than Monotherapy In The Treatment Of Vitiligo. ..

Downloads

Download data is not yet available.

References

Berti S , Buggiani G, Lotti T. Use of Tacrolimus ointment in Vitiligo alone or in combination therapy. Skin Therapy Letter. 2009;19:4.

2. Szczurko O , Heather SB . A systematic review of natural health product treatment for vitiligo. Br J Dermatol. 2008;8:2.

3. Garg BJ , Saraswat A , Bhatia A , Katare OP . Topical treatment in vitiligo and the potential uses of new drug delivery systems. Indian J Dermatol Venereol. 2010;76(3):231-38.

4. Wazir SM, Paracha M M, Khan SU. Efficacy and safety of topical mometasone furoate 0.01% vs. Tacrolimus 0.03% and mometasone furoate 0.01%in vitiligo. J Pak Assoc Dermatol. 2010;20:89-92.

5. Yaghoobi R, Omidian M, Bagherani N. Comparison of therapeutic efficacy of topical corticosteroids and oral zinc sulphate-topical corticosteroid combination in the treatment of vitiligo patients. BMC Dermatol. 2011;11:7.

6. Nordal EJ, Guleng GE, Ronnevig JR . Treatment of vitiligo with narrowband-UVB (TL01) combined with Tacrolimus ointment (0.1%) vs. placebo ointment, a randomized right ⁄ left double-blind comparative study. J Eur Acad Dermatol Venereol. 2011;25(12): 1440-3 .

7. Berti S, Buggiani G, Lotti T. Use of Tacrolimus Ointment in Vitiligo Alone or in Combination Therap. Skin Therapy Letter. 2013;18:7.

8. Pacifico A, Leone G. Photo(chemo)therapy for vitiligo. Photodermatology, photoimmunology, and photomedicine. 2011;27:261-77.

9. Majid I. Vitiligo Management: An Update : BJMP 2010;3(3):332.

10. Tamler C , Estrada BD, Oliveira PA , Avelleir JC. Tacrolimus 0.1% ointment in the treatment of vitiligo. An. Bras. Dermatol. 2011;86:1.

11. Bacigalupi, Robert M. Postolova, Ann D, Ronald S . Evidence-Based, Non-Surgical Treatments for Vitiligo. American J Clin Dermatol. 2012;13(4);217-37.

12. Review article Topical Tacrolimus: A boon to dermatology Research Drops Pharma. InterScience Int J Pharm Biomed Sci. 2012;3(4):188-92.

13. Majid I . Does topical Tacrolimus ointment enhances the efficacy of narrow band ultraviolet B therapy in vitiligo. A left-right comparisoson study. Photodermatology, photoimmunology and photomedicine. 2010;26:230-234.

14. Falabella R, Barona MI. Update on skin repigmentation therapies in vitiligo. Pigment Cell Melanoma. 2008 ;17(22):42–65.

15. Köse O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood vitiligo. J Dermatolog Treat. 2010;21:133–9.

16. Köse O, Arca E, Kurumlu Z. Mometasone cream versus pimecrolimus cream for the treatment of childhood vitiligo. J Dermatolog Treat. 2010;21:133–9.

17. Gawkrodger DJ, Ormerod AD, Shaw L, Mauri-Sole I, Whitton ME, Watts MJ, et al. Guideline for the diagnosis and management of vitiligo. B J Dermatol. 2008;159(5):1051–76.

18. Umar BU, Rahman S, Dutta S, Islam T, Nusrat N, Chowdhury K, Ahmad WF, Haque M, Umar BU, Fakuradzi WF. Management of atopic dermatitis: the role of tacrolimus. Cureus. 2022 Aug 18;14(8).

19. Rahmat R, Hussain M, Muzaffar B, Akbar N, Siddiqui A. Comparative Study between Ultraviolet-B Phototherapy Alone and Ultraviolet-B Phototherapy with Topical Tacrolimus in the Treatment of Vitiligo. Pakistan Armed Forces Medical Journal. 2024 Aug 31;74(4):1028.

20. Feturi, F.G., Schnider, J.T., Fanzio, P.M. et al. Pharmacokinetics and Biodistribution of Tacrolimus after Topical Administration: Implications for Vascularized Composite Allotransplantation. Pharm Res 37, 222 (2020). https://doi.org/10.1007/s11095-020-02921-w

21. Bubna, Aditya Kumar. Topical Tacrolimus and Pimecrolimus in Dermatology: An Overview. Clinical Dermatology Review 8(3):p 185-196, Jul–Sep 2024. | DOI: 10.4103/cdr.cdr_121_23

22. Khoso H, Fahim M. A double-blind randomized controlled trial assessing the efficacy of topical steroids alone and combined with tacrolimus for the treatment of chronic hand eczema. J Pak Assoc Dermatol [Internet]. 2024Oct.11 [cited 2026Jan.8];34(4):905-12

23. Sajjad D, Muzaffar B, Siddiqui MA, Hussain M, Aslam S, Farid H. Comparative Efficacy of Topical Tacrolimus 0.1% and Clobetasol Propionate 0.05% in the Treatment of Alopecia Areata (AA): Efficacy of Tacrolimus and Clobetasol Propionate in the Treatment of Alopecia Areata. Pakistan Journal of Health Sciences. 2023 Nov 30:77-80.

24. Liu X, Yao Z, Wang Y, Chai L, Zhou X. Vitamin D analogs combined with different types of phototherapy in the treatment of vitiligo: A systematic review of randomized trials and within-patient studies. International Immunopharmacology. 2022 Aug 1;109:108789.

Downloads

Published

2025-11-15

How to Cite

1.
Rehman S, Azam Khan F, Zahoor H, Taqweem N, Mahmood Noor S, Naheed N. Efficacy of Tacrolimus plus Narrow Band Ultraviolet B Phototherapy versus Narrow Band Ultraviolet B Phototherapy alone in the Treatment of Vitiligo. J Neonatal Surg [Internet]. 2025 Nov. 15 [cited 2026 Apr. 14];14(32S):10271-9. Available from: https://jneonatalsurg.com/index.php/jns/article/view/9866

Issue

Vol. 14 No. 32S (2025): Journal of Neonatal Surgery

Section

Original Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

You are free to:

  • Adapt — remix, transform, and build upon the material for any purpose, even commercially.

Terms:

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.